We showed that CBD significantly reduces the transcript levels of the proinflammatory immune biomarkers IL‐12, CD68, CCL2, and IRF3, found previously upregulated in rodent models of induced epilepsy and in pediatric patients with encephalopathy.37, 56. Here, CCL2 is linked to epilepsy.